Publication | Open Access
Is interim 18F-fluoride PET/CT a predictor of outcomes after radium-223 therapy?
12
Citations
18
References
2019
Year
The skeletal tumor burden on an interim <sup>18</sup>F-fluoride PET/CT, performed after three cycles of <sup>223</sup>RaCl<sub>2</sub>, is not able to predict overall survival, progression-free survival, or time to bone event, and should not be performed to monitor response at this time.
| Year | Citations | |
|---|---|---|
Page 1
Page 1